Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.
07/09/2019
/
Publications
/
Hypofractionation
Pencil Beam Scanning - PBS
A study by the research group in Prague. Two hundred patients with early-stage prostate cancer were treated with IMPT on extreme hypofractionated schedule (36...
Comparative toxicity outcomes of PBT vs IMRT for prostate cancer in the postoperative setting.
07/09/2019
/
Publications
/
Toxicity
A case-matched cohort analysis study compared acute and late genitourinary (GU) and gastrointestinal (GI) toxicity outcomes in patients with prostate cancer (PC...
Particle therapy for prostate cancer: past, present and future.
07/07/2019
/
Publications
A review article by the Japanese researchers about the particle radiotherapy in comparison to photon-based radiation for prostate cancer. Due to a lack of...
Early and late side effects, dosimetric parameters and QoL after PBT and IMRT for prostate cancer
03/03/2019
/
Publications
/
Dosimetry
A study by the researchers of Dresden and Heidelberg. Eighty-eight patients with localized prostate cancer treated with PBT (31) or IMRT (57) were matched using...
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided PT for Prostate Cancer.
03/02/2019
/
Publications
/
Imaging System
A study by the Jacksonville group published in the Green Journal aimed to identify baseline predictive factors that impact long-term erectile function. 676...
Four-year outcomes from a prospective phase II clinical trial of moderately hypofractionated PT for localized prostate cancer.
04/06/2019
/
Publications
Published in the Red Journal, the researchers of Upenn and Groningen reported the clinical and patient-reported outcomes for patients with prostate cancer...
Literature Review of PBT for Prostate Cancer in Japan.
01/01/2019
/
Publications
A literature review on published works related to proton beam therapy for prostate cancer in Japan. 23 articles were analyzed including fourteen observational...
LT results of a phase II study of hypofractionated PT for prostate cancer
01/01/2019
/
Publications
A study by the Korean group of National Cancer Center. Eighty-two patients with T1-3bN0M0 prostate cancer were randomized to one of five arms: Arm 1, 60 cobalt...
Analysis of Gastrointestinal Toxicity in Patients Receiving PBT for Prostate Cancer
08/08/2018
/
Publications
/
Toxicity
A study by the Seattle group. 192 prostate cancer patients were treated with PBT. With the median follow-up of 1.7 years, most of the observed GI toxicity (>90%...
Initial toxicity, QoL outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated vs. standard fractionated PT for low-risk prostate cancer
08/02/2018
/
Publications
/
Hypofractionation
Quality of life
A multi-center prospective phase 3 randomized trial aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.